Mast cells play a pivotal role in the pathogenesis of asthma and other allergic diseases. These reactions are generally initiated by antigen-dependent aggregation of the high affinity IgE receptor (Fc-epsilon-RI) expressed on the cell surface and subsequent release of pro-inflammatory mediators (e.g. histamine, prostanoids, proteases and cytokines). Ligands for other receptors such as KIT and various GPCRs may serve to prime mast cells for, or act as co-activators of, antigen-mediated mast cell activation. The signaling pathways linking Fc-epsilon-RI aggregation to human mast cell activation and function and how other receptors modify these Fc-mediated signaling events are not well understood. Thus the primary focus of the research is the elucidation of signaling mechanisms associated with the activation of mast cells via the Fc-epsilon-RI and especially how the signaling pathways initiated by other receptors may integrate with those initiated by the Fc-epsilon-RI for synergistic mast cell activation and/or inhibition. The ability of mast cells to impact disease states in vivo also depends on their growth and differentiation from their progenitor cells, migration of the mast cells to their resident tissues, and their survival at these sites. Therefore, the integrated receptor-mediated signaling events regulating these processes are also being examined. The following observations were made since the last report: i. Under acute conditions, SCF enhances mast cell activation while chronic exposure to SCF appears to protect against fatal antigen-mediated anaphylaxis. We investigated this dichotomy by examining the manifestations of extended exposure to SCF as occurs in vivo. Mouse bone marrow-derived mast cells exposed to SCF for more than 72 hours displayed a marked attenuation of FceRI-mediated degranulation and cytokine production. The hypo-responsive phenotype was associated with a marked down-regulation of expression of the SRC kinase Hck and defective cytoskeletal reorganization. As such, these findings have important ramifications for the understanding of the homeostatic control of mast cell activation. ii.Similarly, we discovered that long-term exposure of human and mouse mast cells to IL-33 results in a substantial reduction of mast cell activation in response to antigen as a consequence of MyD88-dependent attenuation of signaling processes necessary for mast cell activation including antigen-mediated calcium mobilization and cytoskeletal reorganization. These changes were possibly a consequence of down-regulation of the expression of PLCg1 and Hck. iii. Migration of mast cells to sites of inflammation is regulated by chemotactic factors such as stem cell factor (SCF). Despite inducing similar early signaling events to antigen, chemotactic factors, including SCF, produce minimal degranulation in the absence of other stimuli. We therefore investigated whether processes regulating mast cell chemotaxis are rate limiting for mast cell mediator release. In these experiments, we disrupted actin polymerization, a requirement for mast cell chemotaxis, then examined chemotaxis and mediator release in human mast cells induced by antigen or SCF. We found that disruption minimally affected early signaling pathways, but attenuated SCF-induced human mast cell chemotaxis. Unexpectedly, however, in the absence of other stimuli, SCF induced substantial degranulation in a concentration-dependent manner following actin disassembly. We interpret this data as consistent with the conclusion that processes regulating cell migration limit mast cell degranulation as a consequence of cytoskeletal reorganization. iv. Linkage analyses have implicated the MS4A2-containing gene locus (encoding for FceRI) as a candidate for allergy susceptibility. We have identified a truncation of FceRI (t-FceRI) in humans which contains a putative calmodulin binding domain and thus, we sought to identify the role of this variant in mast cell function. We determined that t-FceRI forms a complex with Fyn kinase, Gab2, p85 PI3K and -tubulin. Calmodulin bound to t-FceRI in the presence of Ca2+ initiating phosphorylation, which was critical for t-FceRI function. Confocal microscopy demonstrated localization of the t-FceRI complex to the Golgi surrounding the centrosome after IgE-dependent and IgE-independent activation. Knockdown of t-FceRI attenuated microtubule formation, degranulation and IL-8 production downstream of Ca2+ signals. These observations are consistent with the conclusion that t-FceRI mediates Ca2+-dependent microtubule formation, which promotes degranulation and cytokine release. v. We have derived a novel mouse MC line which allows the study of normal and mutated KIT constructs. These cells originated from a bone marrow-derived mouse mast cell culture as a rapidly dividing mast cell sub-population. Over time, these cells lost KIT expression while continuing to express functional high affinity receptors for IgE. Retroviral transduction of the cells with a human KIT construct resulted in surface expression of human KIT which responded to human stem cell factor (KIT ligand). This cell line thus presents a novel system to delineate how mast cell function is modulated by native and mutated KIT and for the identification of inhibitors of these processes.

Project Start
Project End
Budget Start
Budget End
Support Year
8
Fiscal Year
2013
Total Cost
$603,643
Indirect Cost
City
State
Country
Zip Code
Kim, Do-Kyun; Beaven, Michael A; Metcalfe, Dean D et al. (2018) Interaction of DJ-1 with Lyn is essential for IgE-mediated stimulation of human mast cells. J Allergy Clin Immunol 142:195-206.e8
Kulinski, Joseph M; Proia, Richard L; Larson, Elisabeth M et al. (2018) S1P? Regulates Passive Systemic Anaphylaxis in Mice but Is Dispensable for Canonical IgE-Mediated Responses in Mast Cells. Int J Mol Sci 19:
Olivera, Ana; Beaven, Michael A; Metcalfe, Dean D (2018) Mast cells signal their importance in health and disease. J Allergy Clin Immunol 142:381-393
Bandara, Geethani; Muñoz-Cano, Rosa; Tobío, Araceli et al. (2018) Targeting Sphingosine Kinase Isoforms Effectively Reduces Growth and Survival of Neoplastic Mast Cells With D816V-KIT. Front Immunol 9:631
Yin, Yuzhi; Bai, Yun; Olivera, Ana et al. (2017) An optimized protocol for the generation and functional analysis of human mast cells from CD34+ enriched cell populations. J Immunol Methods 448:105-111
Desai, Avanti; Jung, Mi-Yeon; Olivera, Ana et al. (2016) IL-6 promotes an increase in human mast cell numbers and reactivity through suppression of suppressor of cytokine signaling 3. J Allergy Clin Immunol 137:1863-1871.e6
Boyden, Steven E; Desai, Avanti; Cruse, Glenn et al. (2016) Vibratory Urticaria Associated with a Missense Variant in ADGRE2. N Engl J Med 374:656-63
Metcalfe, Dean D; Pawankar, Ruby; Ackerman, Steven J et al. (2016) Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases. World Allergy Organ J 9:7
Kulinski, Joseph M; Muñoz-Cano, Rosa; Olivera, Ana (2016) Sphingosine-1-phosphate and other lipid mediators generated by mast cells as critical players in allergy and mast cell function. Eur J Pharmacol 778:56-67
Cruse, Glenn; Yin, Yuzhi; Fukuyama, Tomoki et al. (2016) Exon skipping of Fc?RI? eliminates expression of the high-affinity IgE receptor in mast cells with therapeutic potential for allergy. Proc Natl Acad Sci U S A 113:14115-14120

Showing the most recent 10 out of 48 publications